Financial information

Financial guidance 2021

in € million

Guidance 2021
(updated on July 26, 2021)

Results 2020

Group Revenues 155 to 180* 327.7
Operating Expenses 435 to 465** 309.7
Share of R&D in Operating Expenses (in %) 52 to 57% 45.7%

*This forecast on Group revenues includes the announced € 16 million milestone payments from GSK, but excludes other potential significant milestones from development partners and/or licensing partnerships. This revenue guidance is subject to a number of uncertainties including the potential for variability from the first full year of the Monjuvi product launch, the limited visibility that MorphoSys has on the Tremfya royalty stream as well as the ongoing COVID-19 pandemic and the impact on our as well as our partner’s business operations. The updated revenue guidance primarily reflects updated Monjuvi product sales expectations. 

**Operating expenses, inclusive of Incyte’s share of Monjuvi selling costs. The updated guidance for Group operating expenses mainly reflects the acquisition of Constellation Pharmaceuticals (Constellation), which was completed on July 15, 2021. The revised Group range also includes one-time transaction costs of € 36 million, related to the agreements with Constellation and Royalty Pharma. 

Fundamentals of
MorphoSys Group

Reports

 
PDF-Download
Online Version
Order Printed Version

2021

  1. Half-Year Report 2021

    Download
    Online
    Order
     
  2. 1st Quarter Interim Statement 2021*

    Download
    Online
    Order
     

2020

  1. Non-financial Report 2020

    Download
    Online
    Order
     
  2. Form 20-F 2020

    Download
    Online
    Order
     
  3. Financial Statements 2020 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  4. 3rd Quarter Interim Statement 2020

    Download
    Online
    Order
     
  5. Half-Year Report 2020

    Download
    Online
    Order
     
  6. 1st Quarter Interim Statement 2020

    Download
    Online
    Order
     

2019

  1. Form 20-F 2019

    Download
    Online
    Order
     
  2. Financial Statements 2019 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. 3rd Quarter Interim Statement 2019

    Download
    Online
    Order
     
  4. Half-Year Report 2019

    Download
    Online
    Order
     
  5. 1st Quarter Interim Statement 2019

    Download
    Online
    Order
     

2018

  1. Form 20-F incl. Management Report

    Download
    Online
    Order
     
  2. Financial Statements 2018 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. 3rd Quarter Interim Statement 2018

    Download
    Online
    Order
     
  4. Half-Year Report 2018

    Download
    Online
    Order
     
  5. 1st Quarter Interim Statement 2018

    Download
    Online
    Order
     

2017

  1. Financial Statements 2017 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  2. 3rd Quarter Interim Statement 2017

    Download
    Online
    Order
     
  3. Half-Year Report 2017

    Download
    Online
    Order
     
  4. 1st Quarter Interim Statement 2017

    Download
    Online
    Order
     

2016

  1. Annual Report 2016

    Download
    Online
    Order
  2. Financial Statements 2016 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. 3rd Quarter Interim Statement 2016

    Download
    Online
    Order
     
  4. Half-Year Report 2016

    Download
    Online
    Order
     
  1. 1st Quarter Interim Statement 2016

    Download
    Online
    Order
     

2015

  1. Financial Statements 2015 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  2. Consolidated Financial Statements (IFRS) 2015

    Download
    Online
    Order
     
  3. Nine Months' Report 2015

    Download
    Online
    Order
     
  4. Six Months' Report 2015

    Download
    Online
    Order
     
  5. Three Months’ Report 2015

    Download
    Online
    Order
     

2014

  1. Financial Statements 2014 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  2. Consolidated Financial Statements (IFRS) 2014

    Download
    Online
    Order
     
  3. Nine Months' Report 2014

    Download
    Online
    Order
     
  4. Six Months' Report 2014

    Download
    Online
    Order
     
  5. Three Months' Report 2014

    Download
    Online
    Order
     

2013

  1. Financial Statements 2013 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  2. Consolidated Financial Statements (IFRS) 2013

    Download
    Online
    Order
     
  3. Nine Months' Report 2013

    Download
    Online
    Order
     
  4. Six Months' Report 2013

    Download
    Online
    Order
     
  5. Three Months' Report 2013

    Download
    Online
    Order
     

2012

  1. Consolidated Financial Statements (IFRS) 2012

    Download
    Online
    Order
     
  2. Financial Statements 2012 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. Nine Months' Report 2012

    Download
    Online
    Order
     
  4. Six Months' Report 2012

    Download
    Online
    Order
     
  5. Three Months' Report 2012

    Download
    Online
    Order
     

2011

  1. Consolidated Financial Statements (IFRS) 2011

    Download
    Online
    Order
     
  2. Financial Statements 2011 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. Nine Months' Report 2011

    Download
    Online
    Order
     
  4. Six Months' Report 2011

    Download
    Online
    Order
     
  5. Three Months' Report 2011

    Download
    Online
    Order
     

2010

  1. Consolidated Financial Statements (IFRS) 2010

    Download
    Online
    Order
     
  2. Financial Statements 2010 of MorphoSys AG (German GAAP - HGB)

    Download
    Online
    Order
     
  3. Nine Months' Report 2010

    Download
    Online
    Order
     
  4. Six Months' Report 2010

    Download
    Online
    Order
     
  5. Three Months’ Report 2010

    Download
    Online
    Order
     

*Note: The previous version of the First Quarter Interim Statement January – March 2021 was replaced by this one due to an editorial mistake in R&D expenses on page 15

In-house produced with firesys

 

See MorphoSys' SEC-Filings

Related Links